Is the use of machine learning in head and neck cancer radiotherapy supported by clinical trials?
Open Access
- 1 July 2025
- journal article
- review article
- Published by Elsevier in Physica Medica
- Vol. 136, 105036
Abstract
No abstract availableKeywords
Funding Information
- UEFISCDI (PN-IV-P1-PCE-2023\u20130042)
- Ministerul Cercetării şi Inovării
- Ministerul Cercetării, Inovării şi Digitalizării
This publication has 68 references indexed in Scilit:
- Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinomaHead & Neck, 2023
- Using machine learning to predict gamma passing rate in volumetric‐modulated arc therapy treatment plansJournal of Applied Clinical Medical Physics, 2022
- Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapyCPT: Pharmacometrics & Systems Pharmacology, 2021
- MRI-Based radiomics nomogram for differentiation of benign and malignant lesions of the parotid glandEuropean Radiology, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy DrugsJAMA Network Open, 2019
- Automatic treatment planning based on three‐dimensional dose distribution predicted from deep learning techniqueMedical Physics, 2018
- Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent ChemotherapyJAMA Oncology, 2018
- Detecting oropharyngeal carcinoma using multispectral, narrow‐band imaging and machine learningThe Laryngoscope, 2018
- Head and neck cancerCancer, 2008